| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
22 Jan 2026 |
2 |
$0 |
4 |
EVP, Chief Scientific Officer |
26 Jan 2026, 16:10 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
15 May 2025 |
1 |
-$22,084 |
4 |
EVP, Chief Scientific Officer |
19 May 2025, 17:07 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
13 Mar 2025 |
1 |
-$1,647,810 |
4 |
EVP, Chief Scientific Officer |
17 Mar 2025, 16:09 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
10 Mar 2025 |
1 |
-$1,615,500 |
4 |
EVP, Chief Scientific Officer |
12 Mar 2025, 16:08 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
03 Mar 2025 |
1 |
-$1,583,190 |
4 |
EVP, Chief Scientific Officer |
05 Mar 2025, 16:08 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
26 Feb 2025 |
2 |
-$3,466,158 |
4 |
EVP, Chief Scientific Officer |
28 Feb 2025, 16:23 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
24 Feb 2025 |
2 |
-$2,326,950 |
4 |
EVP, Chief Scientific Officer |
26 Feb 2025, 16:04 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
20 Feb 2025 |
1 |
-$533,280 |
4 |
EVP, Chief Scientific Officer |
24 Feb 2025, 16:07 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
14 Feb 2025 |
1 |
-$1,062,714 |
4 |
EVP, Chief Scientific Officer |
19 Feb 2025, 16:19 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
12 Feb 2025 |
1 |
$0 |
4 |
EVP, Chief Scientific Officer |
14 Feb 2025, 16:03 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
10 Feb 2025 |
1 |
-$1,002,413 |
4 |
EVP, Chief Scientific Officer |
12 Feb 2025, 16:21 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
04 Feb 2025 |
2 |
$0 |
4 |
EVP, Chief Scientific Officer |
06 Feb 2025, 16:07 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
15 Nov 2024 |
1 |
-$7,178 |
4 |
EVP, Chief Scientific Officer |
19 Nov 2024, 16:08 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
15 May 2024 |
1 |
-$23,270 |
4 |
EVP, Chief Scientific Officer |
17 May 2024, 16:22 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
23 Feb 2024 |
2 |
-$3,518,749 |
4 |
EVP, Global Research and CSO |
27 Feb 2024, 16:24 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
21 Feb 2024 |
1 |
-$1,266,154 |
4 |
EVP, Global Research and CSO |
23 Feb 2024, 16:10 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
16 Feb 2024 |
3 |
-$4,456,710 |
4 |
EVP, Global Research and CSO |
21 Feb 2024, 16:13 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
09 Feb 2024 |
2 |
-$2,208,986 |
4 |
EVP, Global Research and CSO |
13 Feb 2024, 16:46 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
06 Feb 2024 |
3 |
$0 |
4 |
EVP, Global Research and CSO |
08 Feb 2024, 16:10 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
15 Nov 2023 |
1 |
-$7,028 |
4 |
EVP, Global Research and CSO |
17 Nov 2023, 16:11 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
09 Aug 2023 |
1 |
-$21,767 |
4 |
EVP, Global Research and CSO |
11 Aug 2023, 16:05 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
24 Feb 2023 |
4 |
-$2,366,256 |
4 |
EVP, Global Research and CSO |
28 Feb 2023, 15:40 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
17 Feb 2023 |
5 |
-$2,273,864 |
4 |
EVP, Global Research and CSO |
22 Feb 2023, 15:25 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
14 Feb 2023 |
6 |
-$1,911,108 |
4 |
EVP, Global Research and CSO |
16 Feb 2023, 15:11 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
10 Feb 2023 |
6 |
-$4,239,380 |
4 |
EVP, Global Research and CSO |
14 Feb 2023, 15:49 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
06 Feb 2023 |
8 |
-$154,483 |
4 |
EVP, Global Research and CSO |
08 Feb 2023, 15:53 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
01 Feb 2023 |
3 |
$0 |
4 |
EVP, Global Research and CSO |
03 Feb 2023, 15:30 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
15 Nov 2022 |
1 |
-$10,493 |
4 |
EVP, Global Research and CSO |
17 Nov 2022, 15:08 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
07 Nov 2022 |
9 |
-$150,507 |
4 |
EVP, Global Research and CSO |
09 Nov 2022, 15:40 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
08 Aug 2022 |
7 |
-$136,930 |
4 |
EVP, Global Research and CSO |
10 Aug 2022, 16:06 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
19 Jul 2022 |
8 |
-$2,059,782 |
4 |
EVP, Global Research and CSO |
21 Jul 2022, 16:48 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
24 Feb 2022 |
5 |
-$3,124,808 |
4 |
EVP, Global Research and CSO |
28 Feb 2022, 16:18 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
17 Feb 2022 |
6 |
-$1,795,551 |
4 |
EVP, Global Research and CSO |
22 Feb 2022, 15:51 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
14 Feb 2022 |
1 |
-$567,057 |
4 |
EVP, Global Research and CSO |
16 Feb 2022, 15:05 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
10 Feb 2022 |
5 |
-$1,376,206 |
4 |
EVP, Global Research and CSO |
14 Feb 2022, 15:11 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
01 Feb 2022 |
12 |
-$1,171,842 |
4 |
EVP, Global Research and CSO |
03 Feb 2022, 15:06 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
15 Nov 2021 |
2 |
-$6,365 |
4 |
EVP, Global Research and CSO |
16 Nov 2021, 15:04 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA |
17 May 2021 |
3 |
-$17,093 |
4 |
EVP, Global Research and CSO |
19 May 2021, 16:02 |